{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Anaheim",
      "address_1": "1250 N Lakeview Ave Ste O",
      "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.",
      "address_2": "",
      "product_quantity": "9 bottles consisting of 90 tables each bottle",
      "code_info": "Lot # G2017F  NDC 68788-6882-9",
      "center_classification_date": "20180817",
      "distribution_pattern": "Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.",
      "state": "CA",
      "product_description": "Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9",
      "report_date": "20180829",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Preferred Pharmaceuticals, Inc",
      "recall_number": "D-1107-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "80840",
      "termination_date": "20190118",
      "more_code_info": "",
      "recall_initiation_date": "20180815",
      "postal_code": "92807-1801",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}